H.R. 19 · 116th Congress
Lower Costs, More Cures Act of 2019
- Stage
- In committee
- Sponsor
- Greg Walden
- Introduced
- 2019-12-09
- Latest action
- 2019-12-19 · Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Subjects
Appropriations
Executive agency funding and structure
Medicare
Administrative law and regulatory procedures
Congressional oversight
Health care costs and insurance
Income tax deductions
Government studies and investigations
Health
Health information and medical records
User charges and fees
Civil actions and liability
Income tax exclusion
Medicaid
State and local government operations
Inflation and prices
Fraud offenses and financial crimes
Child health
Medical research
Digestive and metabolic diseases
Women's health
Licensing and registrations
Cancer
Health programs administration and funding
Drug therapy
Medical tests and diagnostic methods
Advisory bodies
Home and outpatient care
Department of Health and Human Services
Health technology, devices, supplies
Health personnel
Genetics
Trade agreements and negotiations
Research and development
Intergovernmental relations
Government information and archives
Consumer affairs
Chemistry
Immunology and vaccination
Intellectual property
Medical education
Prescription drugs
Corporate finance and management
Marketing and advertising
Retail and wholesale trades
Competition and antitrust
Public participation and lobbying
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Business records
Manufacturing
Product development and innovation
Hospital care
Administrative remedies
Judicial review and appeals
Office of the U.S. Trade Representative
Federal Trade Commission (FTC)
Biological and life sciences
Cosmetics and personal care